CMEC 19th meeting, 6-7 April 2000
Complementary Medicines Evaluation Committee
Extracted ratified minutes
CMEC Meeting 19 extracted ratified minutes (pdf,33kb)
Public recommendation summary
Item 3 Report of the Working Party on Substantiation of Claims
Recommendation 19.1
CMEC endorses the work in progress on the amended document Guidelines for levels and kinds of evidence to support claims for therapeutic goods.
Item 6.1 Papain
Recommendation 19.2
CMEC recommends to the TGA that papain is suitable for use as an active ingredient in listable therapeutic goods, without any substance-specific restrictions.
Item 6.2 Methionine
Recommendation 19.3
CMEC recommends to the TGA that L-methionine is suitable for use as an active ingredient in listable therapeutic goods, without any substance-specific restrictions.
Item 6.4 Chondroitin sulfate
Recommendation 19.4
CMEC recommends to the TGA that bovine- and shark-chondroitin sulfate are suitable for use as active ingredients in listable therapeutic goods, without any substance-specific restrictions.